Alzinova’s CEO: “We are a top actor in the Alzheimer’s field”
Alzinova has appointed board member Dr Carol Routledge as acting CEO.
The move comes as the company continues its search for a permanent CEO after Kristina Torfgård announced her resignation from the post in the spring.